Angiogenesis as a biomarker and target in cancer chemoprevention
Authors:
- Ricky A SharmaRSRicky A Sharma
- Adrian L HarrisAHAdrian L Harris
- Angus G DalgleishADAngus G Dalgleish
- William P StewardWSWilliam P Steward
- Kenneth J O'BYrneKOKenneth J O'BYrne
- 1 December 2001
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 2 (12) , 726-732
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Colorectal cancer chemopreventionEuropean Journal of Cancer, 2001
- Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinomaCancer, 2000
- Human Hepatitis B Virus X Protein Is a Possible Mediator of Hypoxia-Induced Angiogenesis in HepatocarcinogenesisBiochemical and Biophysical Research Communications, 2000
- The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant diseaseEuropean Journal of Cancer, 2000
- Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in MiceScience, 1999
- The angiogenic switch in hamster buccal pouch keratinocytes is dependent on TGFbeta-1 and is unaffected by ras activationCarcinogenesis, 1997
- MOLECULAR PATHOBIOLOGY AND IMMUNOLOGY OF MALIGNANT MESOTHELIOMAThe Journal of Pathology, 1996
- Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin‐1: a potential mechanism for inflammatory angiogenesisFEBS Letters, 1995
- Expression of the angiogenic phenotype by a subpopulation of keratinocytes derived from 7,12-dimethylbenz[a]anthracene-initiated hamster buccal pouch epitheliumCarcinogenesis, 1988
- Activated macrophages induce vascular proliferationNature, 1977